The epidemiology of systemic lupus erythematosus (SLE) in Africa is largely undetermined, and the perception persists that the incidence of SLE on the continent is very low. Recent studies as well as our own experience, however, suggest that this is not the case. We have conducted a survey amongst medical practitioners in Africa to determine their experiences of diagnosing and treating SLE patients, and the results suggest that significant numbers of African patients are presenting with SLE. The apparent low incidence rate in Africa may be the result of underdiagnosis due to poor access to health care, low disease recognition within primary health care settings, limited access to diagnostic tools and inadequate numbers of specialist physicians. Treatment of SLE in Africa is also restricted by availability and affordability of immunosuppressive drugs. We have established the African Lupus Genetics Network (ALUGEN), an informal network of clinicians and researchers in Africa who have an interest in SLE, in order to facilitate combined clinical and research efforts towards improved outcomes for African SLE patients.
TiffinNAdeyemoAOkpechiI. A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus. Orphanet J Rare Dis2013; 8: 2–2.
2.
SiegelMLeeSL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum1973; 3: 1–54.
3.
Goldman MB, Hatch MC. Women and health. Academic Press (U.S.A.), 1999.
4.
DanchenkoNSatiaJAAnthonyMS. Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden. Lupus2006; 15: 308–318.
5.
KumarKChambersSGordonC. Challenges of ethnicity in SLE. Best Pract Res Clin Rheumatol2009; 23: 549–561.
6.
GreenwoodBM. Autoimmune disease and parasitic infections in Nigerians. Lancet1968; 2: 380–382.
7.
SymmonsDP. Frequency of lupus in people of African origin. Lupus1995; 4: 176–178.
8.
ButcherGA. Malaria and macrophage function in Africans: A possible link with autoimmune disease?Med Hypotheses1996; 47: 97–100.
9.
ClarkIAal-YamanFMCowdenWBRockettKA. Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa?Lancet1996; 348: 1492–1494.
10.
AdebajoAO. Low frequency of autoimmune disease in tropical Africa. Lancet1997; 349: 361–362.
11.
BaeS-CFraserPLiangMH. The epidemiology of systemic lupus erythematosus in populations of African ancestry: A critical review of the “prevalence gradient hypothesis”. Arthritis Rheum1998; 41: 2091–2099.
12.
TiklyMBurginSMohanlalPBellinganAGeorgeJ. Autoantibodies in black South Africans with systemic lupus erythematosus: Spectrum and clinical associations. Clin Rheumatol1996; 15: 261–265.
13.
MolokhiaMMcKeiguePMCuadradoMHughesG. Systemic lupus erythematosus in migrants from west Africa compared with Afro-Caribbean people in the UK. Lancet2001; 357: 1414–1415.
14.
FallerGThomsonPDKalaUKHahnD. Demographics and presenting clinical features of childhood systemic lupus erythematosus. S Afr Med J2005; 95: 424–427.
15.
AbdouNBoucarDEl Hadj FaryKA. Histopathological profiles of nephropathies in Senegal. Saudi J Kidney Dis Transplant2003; 14: 212–214.
16.
AdelowoOOOguntonaSA. Pattern of systemic lupus erythematosus among Nigerians. Clin Rheumatol2009; 28: 699–703.
17.
UribeAGMcGwinG JrReveilleJDAlarcónGS. What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading?Autoimmun Rev2004; 3: 321–329.
18.
UribeAGViláLMMcGwinG JrSanchezMLReveilleJDAlarcónGS. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol2004; 31: 1934–1940.
19.
WadeeSTiklyMHopleyM. Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatol Oxf Engl2007; 46: 1487–1491.
20.
AnsellSMBedhesiSRuffB. Study of critically ill patients with systemic lupus erythematosus. Crit Care Med1996; 24: 981–984.
21.
HodkinsonBMusengeETiklyM. Osteoarticular tuberculosis in patients with systemic lupus erythematosus. QJM2009; 102: 321–328.
22.
GouldTTiklyM. Systemic lupus erythematosus in a patient with human immunodeficiency virus infection – challenges in diagnosis and management. Clin Rheumatol2004; 23: 166–169.
23.
BarsoumRSFrancisMR. Spectrum of glomerulonephritis in Egypt. Saudi J Kidney Dis Transpl2000; 11: 421–429.
24.
IbrahimSFayedAFaddaSBelalD. A five-year analysis of the incidence of glomerulonephritis at Cairo University Hospital-Egypt. Saudi J Kidney Dis Transplant2012; 23: 866–870.
25.
Van RensburgBWJvan StadenAMRossouwGJJoubertG. The profile of adult nephrology patients admitted to the Renal Unit of the Universitas Tertiary Hospital in Bloemfontein, South Africa from 1997 to 2006. Nephrol Dial Transplant2010; 25: 820–824.
26.
OkpechiISwanepoelCDuffieldM. Patterns of renal disease in Cape Town South Africa: A 10-year review of a single-centre renal biopsy database. Nephrol Dial Transplant2011; 26: 1853–1861.
27.
AbdelraheemMBAli El-TMMohamedRM. Pattern of glomerular diseases in Sudanese children: A clinico-pathological study. Saudi J Kidney Dis Transplant2010; 21: 778–783.
28.
MesquitaMFossoCBakoto SolE. Renal biopsy findings in Belgium: A retrospective single center analysis. Acta Clin Belg2011; 66: 104–109.
29.
PolitoMGde MouraLARKirsztajnGM. An overview on frequency of renal biopsy diagnosis in Brazil: Clinical and pathological patterns based on 9,617 native kidney biopsies. Nephrol Dial Transplant2010; 25: 490–496.
30.
LiL-SLiuZ-H. Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies. Kidney Int2004; 66: 920–923.
31.
RychlíkIJancováETesarV. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994–2000. Nephrol Dial Transplant2004; 19: 3040–3049.
32.
SchenaFP. Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology. Nephrol Dial Transplant1997; 12: 418–426.
33.
HuraibSAl KhaderAShaheenFA. The spectrum of glomerulonephritis in Saudi Arabia: The results of the Saudi registry. Saudi J Kidney Dis Transplant2000; 11: 434–441.
34.
NaumovicRPavlovicSStojkovicDBasta-JovanovicGNesicV. Renal biopsy registry from a single centre in Serbia: 20 years of experience. Nephrol Dial Transplant2009; 24: 877–885.
35.
RiveraFLópez-GómezJMPérez-GarcíaR.Spanish Registry of Glomerulonephritis. Frequency of renal pathology in Spain 1994–1999. Nephrol Dial Transplant2002; 17: 1594–1602.
36.
KhalifaEHKaballoBGSuleimanSMKhalilEAEl-HassanAM. Pattern of glomerulonephritis in Sudan: Histopathological and immunofluorescence study. Saudi J Kidney Dis Transplant2004; 15: 176–179.
37.
ElkhatibMElnahedMSFaddaSEldeebMSaadiG. The change in the spectrum of glomerulonephritis in Egypt over the past decade. Saudi J Kidney Dis Transplant2012; 23: 1065–1067.
38.
OkpechiIGSwanepoelCRTiffinNDuffieldMRaynerBL. Clinicopathological insights into lupus nephritis in South Africans: A study of 251 patients. Lupus2012; 21: 1017–1024.
39.
AlarcónGSMcGwinG JrBartolucciAA. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum2001; 44: 2797–2806.
40.
KrishnanEHubertHB. Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis2006; 65: 1500–1505.
41.
Ayodele OE, Okpechi IG, Swanepoel CR. Long-term renal outcome and complications in South Africans with proliferative lupus nephritis. Int Urol Nephrol. Epub ahead of print 10 January 2013.
42.
SabryAAbo-ZenahHMedhatTSheashaaHMahmoudKEl-HuseiniA. A comparative study of two intensified pulse cyclophosphamide remission-inducing regimens for diffuse proliferative lupus nephritis: An Egyptian experience. Int Urol Nephrol2009; 41: 153–161.
43.
OkpechiIGAyodeleOEJonesESWDuffieldMSwanepoelCR. Outcome of patients with membranous lupus nephritis in Cape Town South Africa. Nephrol Dial Transplant2012; 27: 3509–3515.
44.
AyodeleOEOkpechiIGSwanepoelCR. Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis. Nephrol Carlton Vic2010; 15: 482–490.
45.
KammounKJarrayaFBouhamedL. Poor prognostic factors of lupus nephritis. Saudi J Kidney Dis Transplant2011; 22: 727–732.
46.
BenithaRTiklyM. Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol2007; 26: 24–29.
47.
The World Health Organization. The World Health Report 2002: Reducing risks, promoting healthy life, http://www.who.int/whr/2002/en/whr02_en.pdf (2002, accessed 13 June 2013).
48.
EkwomPE. Systemic lupus erythematosus (SLE) at the Kenyatta National Hospital. Clin Rheumatol2013; 32: 1215–1217.
49.
KatzIJGerntholtzTNaickerS. Africa and nephrology: The forgotten continent. Nephron Clin Pract2011; 117: c320–c327.
50.
UribeAGHoKTAgeeBMcGwinG Jr. Relationship between adherence to study and clinic visits in systemic lupus erythematosus patients: Data from the LUMINA cohort. Lupus2004; 13: 561–468.
51.
Health Metrics Network: What it is, what it will do and how countries can benefit. The World Health Organization/Health Metrics Network,www.who.int/healthmetrics/about/concept_paper.doc (2005, accessed 6 July 2013).
52.
MeyerPWAHodkinsonBAllyM. HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients. Arthritis Res Ther2011; 13: R160–R160.
53.
DieyeADialloSDiattaM. Identification of HLA-DR alleles for susceptibility to rheumatoid polyarthritis in Senegal [in French]. Dakar Médical1997; 42: 111–113.
54.
HoumanMHSmiti-KhanfirMBen GhorbellIMiledM. Systemic lupus erythematosus in Tunisia: Demographic and clinical analysis of 100 patients. Lupus2004; 13: 204–211.
55.
TaylorHGSteinCM. Systemic lupus erythematosus in Zimbabwe. Ann Rheum Dis1986; 45: 645–648.
